ATXN2 and amyotrophic lateral sclerosis: Moreover, intermediate-length (27–33) polyQ expansions in ataxin-2 (ATXN2) are associated with an increased risk of ALS, while expansions of >34 repeats cause spinocerebellar ataxia type 2 (SCA-2) [51].